Please login to the form below

Not currently logged in
Email:
Password:

Hisun

This page shows the latest Hisun news and features for those working in and with pharma, biotech and healthcare.

Pfizer cuts 2013 forecast after weak first quarter

Pfizer cuts 2013 forecast after weak first quarter

of $490m from the transfer of certain product rights to its China-based joint venture with Hisun.

Latest news

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

Latest Intelligence

  • Pharma deals during January 2013 Pharma deals during January 2013

    Watson continues to extend its women's health franchise. Picking up on several of last year's deal trends, Zhejiang Hisun reported the closure of an exclusive option to access ... So the deployment of an option excluding third party access in this case

  • Biosimilars in China Biosimilars in China

    Several joint venture deals between MNCs and Chinese players have been sealed recently: Hisun with Pfizer, Simcere with Merck and Fosun with Lonza.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
90TEN Healthcare

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

Solaris Health looks at the gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics